Skip to main
AHCO
AHCO logo

AdaptHealth Corp (AHCO) Stock Forecast & Price Target

AdaptHealth Corp (AHCO) Analyst Ratings

Based on 5 analyst ratings
Strong Buy
Strong Buy 60%
Buy 40%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

AdaptHealth Corp is poised for significant growth, with expectations of a 12–15% annual topline increase driven by sustained investments in technology and strategic mergers and acquisitions in a fragmented market. The recent acquisition of AeroCare is anticipated to strengthen the company's national footprint and value proposition with payors, facilitating advancements in its connected health strategy. Furthermore, the company's scalable platform and low-cost infrastructure are expected to enhance operational efficiency, leading to strong organic growth and improved margin expansion through effective cross-selling opportunities.

Bears say

AdaptHealth Corp has experienced a decline in both diabetes and sleep revenues, with diabetes revenue dropping 8.0% year-over-year and sleep revenue falling 3.0% year-over-year, indicating challenges in maintaining market share in competitive segments. Additionally, the company has revised its 2025 revenue and adjusted EBITDA guidance downward by $40 million and $5 million, respectively, primarily due to the sale of certain incontinence assets. The overall outlook is further compounded by concerns about acquisition integration challenges and the inability to achieve operating leverage on organic growth, suggesting potential weaknesses in its business model moving forward.

AdaptHealth Corp (AHCO) has been analyzed by 5 analysts, with a consensus rating of Strong Buy. 60% of analysts recommend a Strong Buy, 40% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of AdaptHealth Corp and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About AdaptHealth Corp (AHCO) Forecast

Analysts have given AdaptHealth Corp (AHCO) a Strong Buy based on their latest research and market trends.

According to 5 analysts, AdaptHealth Corp (AHCO) has a Strong Buy consensus rating as of Oct 14, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $13.40, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $13.40, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

AdaptHealth Corp (AHCO)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.